Curis | CRIS - 销售和管理费用





销售和管理费用 更改 日
Alaunos Therapeutics USD 447K 138K 2026-03
Amgen USD 1.72B 134M 2026-06
AstraZeneca USD 5.8B 735M 2026-06
Bayer EUR 3.96B 267M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
CSL USD 1.23B 498M 2025-12
Curis USD 2.96M 1.62M 2026-03
Eli Lilly USD 3.43B 496M 2026-06
Exelixis USD 147.63M 8.03M 2026-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.19B 75M 2026-06
Incyte USD 351.73M 23.64M 2026-06
Merck USD 2.89B 219M 2026-06
Novartis USD 3.24B 101M 2026-06
Pfizer USD 3.41B 496M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Takeda JPY 286.51B 5.48B 2026-06
TG Therapeutics USD 62.32M 10.82M 2026-06
Verastem USD 22.3M 2.14M 2026-03